Emerging approaches in hepatocellular carcinoma.
The incidence of hepatocellular carcinoma (HCC) is predicted to continue to increase over the next 30 years. Surgical intervention, including resection and orthotopic liver transplantation (OLT) is offered to a limited number of patients. Novel approaches to the treatment of patients with HCC are needed. This article aims to review emerging approaches in the care of the HCC patient including systemic treatment, selection of appropriate candidates for OLT, improved imaging to follow treatment response, and management pre-OLT and post-OLT.
Kulik
Laura M
LM
Division of Hepatology, Departments of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. lkulik@nmff.org
Mulcahy
Mary F
MF
Omary
Reed A
RA
Salem
Riad
R
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000379:methods; D006498:Hepatectomy; D006801:Humans; D016031:Liver Transplantation; D018579:Patient Selection; D015021:Yttrium Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D015021:Yttrium Radioisotopes